These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. Eitner F; Ostendorf T; Van Roeyen C; Kitahara M; Li X; Aase K; Gröne HJ; Eriksson U; Floege J J Am Soc Nephrol; 2002 Apr; 13(4):910-917. PubMed ID: 11912250 [TBL] [Abstract][Full Text] [Related]
5. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects. van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190 [TBL] [Abstract][Full Text] [Related]
8. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745 [TBL] [Abstract][Full Text] [Related]
9. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Floege J; Eng E; Young BA; Couser WG; Johnson RJ Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232 [TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740 [TBL] [Abstract][Full Text] [Related]
11. A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D. Hawthorne T; Giot L; Blake L; Kuang B; Gerwien R; Smithson G; Hahne W; Mansfield T; Starling GC; Pochart P; Hoelscher D; Halvorsen YD Int J Clin Pharmacol Ther; 2008 May; 46(5):236-44. PubMed ID: 18538109 [TBL] [Abstract][Full Text] [Related]
12. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769 [TBL] [Abstract][Full Text] [Related]
13. The role of PDGF-D in mesangioproliferative glomerulonephritis. Floege J; van Roeyen C; Boor P; Ostendorf T Contrib Nephrol; 2007; 157():153-8. PubMed ID: 17495455 [TBL] [Abstract][Full Text] [Related]
14. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats. Wu SH; Wu XH; Liao PY; Dong L Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090 [TBL] [Abstract][Full Text] [Related]
15. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Hartner A; Pahl A; Brune K; Goppelt-Struebe M Inflamm Res; 2000 Jul; 49(7):345-54. PubMed ID: 10959556 [TBL] [Abstract][Full Text] [Related]
20. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]